Did you know that your baby’s umbilical cord contains precious life-saving medical resources that can be used for your baby & family? Simply fill out the form below and our professional consultants will share the benefits of storing your baby’s umbilical cord cells and what factors to consider when it comes to choosing a family cord blood bank!
STEP 1: FILL-UP
Fill up the form
STEP 2: CONTACT
Stemlife will contact you or your spouse on the appointment.
STEP 3: REWARD
Receive StemLife Congratulatory Cash Gift (Up to RM 50 Touch-N-Go Reload) when you have attended non-obligatory appointment with StemLife consultant. . Get another RM 50 Touch-N-Go eWallet Reload if you enrol to StemLife's umbilical cord banking service, within a week after the consultation!
During pregnancy, the umbilical cord functions as a lifeline between mother and child. After the baby is born, the cord blood that remains in the umbilical cord and placenta, can be collected as it contains valuable stem cells that have already been proven useful for the treatment of over 80 diseases, including leukaemia, thalassaemia and lymphoma. Recent clinical trials and researches have shown that cord blood stem cell treatment hold great promise in cell-based immunotherapy and regenerative medicine to potentially treat autism, cerebral palsy, brain injury, stroke, spinal cord injury and more. Collecting your baby’s cord blood is a SAFE, PAINLESS, and RISK-FREE procedure for both mother & baby. It is easily collected within a few minutes and only be done right after birth.
Lucas (alias), a young boy was active and normal until he turned 10 years old and he was constantly lethargic and had a poor appetite for no reason. He also had significant weight loss with bouts of fever and vomiting. He had gone through months of seeking treatments in numerous hospitals in Malaysia. In 2017, he was finally diagnosed by doctors that he had chronic myeloid leukaemia. The parents managed to find a match in his youngest sister’s cord blood, which they stored with Stemlife (A subsidiary of Cordlife Group Limited). The transplant took place successfully in 2018 and he is in remission currently.